Mode
Text Size
Log in / Sign up
Phase 2 Completed N=54 Randomized Double-blind Treatment

Robots Paired With tDCS in Stroke Recovery

Source: ClinicalTrials.gov NCT01726673 ↗
Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcomePrimary: Median Change in Upper Extremity Fugl Meyer Assessment Score — 4.5; 6.0; 4; 6 scores on a scale — p=0.256

Summary

The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy alone.

Outcome Measures

OutcomeResultp-value
PRIMARY
Median Change in Upper Extremity Fugl Meyer Assessment Score
4.5; 6.0; 4; 6 0.256
SECONDARY
Median Change in WOLF Motor Function Test (WMFT)
-34; -19; -103; -81.5 1.0
SECONDARY
Median Change in Motor Power Manual Muscle Test Score for the Upper Extremity (MRC)
7; 7; 6; 6 0.680

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • First single focal unilateral lesion with diagnosis verified by brain imaging, which occurred at least 6 months prior
  • Cognitive function sufficient enough to understand experiments and follow instructions
  • Fugl-Meyer assessment of 7 to 58 out of 66 (neither hemiplegic nor fully recovered motor function in the muscles of the shoulder, elbow, and wrist)

Exclusion Criteria

  • Botox treatment within 6 weeks of enrollment
  • Fixed contraction of the affected limb
  • Complete flaccid paralysis of the affected limb
  • History of hemorrhagic stroke
  • Ongoing use of CNS active medications
  • Ongoing use of psychoactive medications
  • Presence of additional potential tDCS/TMS risk factors including damaged skin at site of stimulation, presence of a magnetically/mechanically active implant, metal in the head, family history of epilepsy, and personal history of seizures
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01726673). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search